Swedish Orphan Biovitrum AB (publ)
F:B6E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Swedish Orphan Biovitrum AB (publ)
F:B6E
|
SE |
|
S
|
Savills PLC
F:1YZ
|
UK |
|
Nissan Motor Co Ltd
F:NISA
|
JP |
|
S
|
Sundial Growers Inc
F:14K
|
CA |
|
P
|
Premier Foods PLC
XMUN:FOJ1
|
UK |
|
S
|
Swedish Orphan Biovitrum AB (publ)
XMUN:B6E
|
SE |
|
Burckhardt Compression Holding AG
SIX:BCHN
|
CH |
|
Denka Co Ltd
F:DIK
|
JP |
|
Betsson AB
OTC:BTSBF
|
SE |
|
Arovella Therapeutics Ltd
ASX:ALA
|
AU |
|
Flinders Mines Ltd
ASX:FMS
|
AU |
|
Bapcor Ltd
F:0BS
|
AU |
|
S
|
SBI Holdings Inc
XMUN:ZOF
|
JP |
|
I
|
II-VI Inc
F:II6
|
US |
|
Amada Co Ltd
OTC:AMDWF
|
JP |
|
B
|
Boise Cascade Co
F:BC0
|
US |
|
Kakaku.com Inc
F:KKC
|
JP |
Bankruptcy Probability
Swedish Orphan Biovitrum AB (publ)'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Swedish Orphan Biovitrum AB (publ) Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
150.2B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
177.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Swedish Orphan Biovitrum AB (publ)'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Swedish Orphan Biovitrum AB (publ) has total debt of 7.9B SEK. This includes both short-term (0 SEK) and long-term (7.9B SEK) debt.
You can find a full breakdown on its Balance Sheet.
